
Overview
Data4cure Poland is a company that provides the Biomedical Intelligence® Cloud and CURIE Knowledge Graph™ to pharmaceutical and biotech organizations for drug development. They specialize in data integration, advanced analysis, and knowledge synthesis to support decision-making throughout the research process. Their platform facilitates the analysis of complex biomedical data, including omics and clinical data, to uncover novel insights and relationships.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $8,120 | |
| Profit allocation | No decision | |
| Loans and borrowings | $25,175 | |
| Related parties | 1 items | |
| Parent company | DATA4CURE INC |
Filing timeliness
Financial statements were filed on time, on average 43 days early.
- 202501/07/2026
- 202423/06/2025
- 202306/06/2024
- 202215/06/2023
- 202120/06/2022
- 202011/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Driving AI-powered drug discovery in partnership with Pfizer (videos from PMWC 2025)
Recap of Data4Cure's PMWC 2025 session on knowledge graphs, LLMs and foundation models in pharmaceutical R&D — featuring Pfizer's Paul Rejto and Data4Cure CEO Janusz Dutkowski, and the Data4Cure–Pfizer partnership.

In the News: Drug Information Association's Magazine
Data4Cure's article on Using Semantic AI in Biomedicine appears in the July 2019 issue of the Drug Information Association (DIA) Global Forum Magazine.

Join us at the 2020 Precision Medicine World Conference (PMWC)
Data4Cure is part of the 2020 Precision Medicine World Conference, the largest annual conference dedicated to precision medicine.

Knowledge Graph-based Eco-System for Pharmaceutical R&D (PMWC 2023)
Data4Cure took part in the 2023 Precision Medicine World Conference in Santa Clara, where CEO Janusz Dutkowski gave a talk on a knowledge-graph-based ecosystem for pharmaceutical R&D.

Knowledge graphs and AI for drug discovery and development (PMWC 2025)
Data4Cure CEO Janusz Dutkowski hosts a PMWC 2025 session with Pfizer's Paul Rejto on knowledge graphs and foundation models for enhanced drug development, and the newly announced Data4Cure–Pfizer partnership.

Pharmaceutical companies adopt knowledge graphs to drive R&D (videos from PMWC 2020)
Data4Cure joined the Precision Medicine World Conference to organize a session on semantic knowledge graphs in drug discovery and clinical trials, exploring interpretable semantic AI that combines machine learning and knowledge graphs.
Industry
Offer
- Biomedical data platform
- Biomedical knowledge graph
- Data analysis software
- Therapeutic target discovery software
Websites
- data4cure.comData4Cure — Turn data into curesCloudflare
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Data4cure, Inc. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-07-01.
92 1050 1012 1000 0090 3222 9511
63 1090 1870 0000 0001 5441 7839
17 1050 1012 1000 0090 3222 9503
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cloudimed sp. z o.o. | $4,150,925.84 | cloudimed.pl | ||
| Dotdata Poland sp. z o.o. | $4,074,402.77 | dotdata.com | ||
| Naturalantibody S.A. | $3,143,039.05 | naturalantibody.com | ||
| Evidence Prime sp. z o.o. | $2,703,278.11 | evidenceprime.com | ||
| Creatoriq Europe sp. z o.o. | $2,570,504.34 | creatoriq.com | ||
| Graylight Imaging sp. z o.o. | $2,363,857.48 | graylight-imaging.com | ||
| Easybase sp. z o.o. | $1,880,683.31 | easybase.pl | ||
| Algolytics Technologies sp. z o.o. | $1,599,468.50 | algolytics.com | ||
| Think Project Polska sp. z o.o. | $1,115,941.03 | thinkproject.com | ||
| Dicella sp. z o.o. | $322,185.03 | dicella.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-05 | Address change (Ul. Ludwika Waryńskiego 3a, 00-645, Warszawa → Ul. Puławska 2, 02-566, Warszawa) | |
| 2020-05-28 | Entered in the register |
FAQ
Last updated: 2026-10-07